-+ 0.00%
-+ 0.00%
-+ 0.00%
Enzychem Lifesciences Corrects Quarterly Report Notes to Reflect Standalone Financial Statements
Share
Listen to the news
Enzychem Lifesciences Corrects Quarterly Report Notes to Reflect Standalone Financial Statements
  • Enzychem Lifesciences corrected its third-quarter 2026 report on Nov. 18, replacing consolidated financial statement notes mistakenly included in the standalone notes section.
  • The correction addresses a clerical error in the report originally filed Nov. 16; it was not required by regulators.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Enzychem Lifesciences Corporation published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261118000067), on November 18, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending